Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05781009
PHASE2

Pregnenolone for the Treatment of Alcohol Use Disorder

Sponsor: Yale University

View on ClinicalTrials.gov

Summary

This Phase 2 randomized cotrolled trial (RCT) will assess the safety and efficacy of pregnenolone (PREG; 300 mg/day, b.i.d dosing) vs. placebo (PBO) over a 12 week treatment period, and at 1-month post-treatment follow-up in individuals with Alcohol Use Disorder (AUD).

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

150

Start Date

2024-01-08

Completion Date

2028-07-31

Last Updated

2026-02-02

Healthy Volunteers

No

Interventions

DRUG

Pregnenolone

300mg

DRUG

Placebo

placebo

Locations (1)

The Yale Stress Center: Yale University

New Haven, Connecticut, United States